Skip to main content
SpringerLink
Log in

Gastric Cancer Trials: Implications of the Gastrointestinal Tumor Study Group and the Mount Sinai Medical Center Experience

  • Conference paper
Gastric Carcinoma

  • 55 Accesses

Abstract

The experience of the GITSG offers useful lessons. Physicians can avoid past “mistakes” and refine multidisciplinary treatment strategies of clear-cut therapeutic benefit. Trials had a sufficient number of patients to identify therapeutic manipulation which benefit a select minority. The sum of several manipulations, each of which may have limited applications, offers something for a substantial fraction of the patients in any physician’s practice. As a consequence, it has become necessary to identify the unique features of the individual patient. This review will concentrate on the observations which are relevant to primary physicians, gastroenterologists, and surgeons.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Gastrointestinal Tumor Study Group: Phase II-III chemotherapy studies in advanced gastric cancer. Cancer Treat Rep 1979; 63: 1871.

    Google Scholar 

  2. Gastrointestinal Tumor Study Group: A comparative clinical assessment of combination chemotherapy in the management of advanced gastric carcinoma. Cancer 1982; 49: 1362.

    Article  Google Scholar 

  3. Gastrointestinal Tumor Study Group: Randomized study of combination chemotherapy in unresectable gastric cancer. Cancer 1984; 53: 13.

    Article  Google Scholar 

  4. Bruckner HW, Lokich JJ, Stablein DM: Studies of Baker’s antifol, methotrexate, and Razoxane in advanced gastric cancer. A Gastrointestinal Tumor Study Group Report. Cancer Treat Rep 1982; 66: 1713.

    PubMed  CAS  Google Scholar 

  5. Bruckner HW, Stablein DM, for the Gastrointestinal Tumor Study Group: A randomized study of 5-fluorouracil and doxorubicin with semustine, cisplatin, or triazinate for treatment of advanced gastric cancer, abstract. Proc ASCO 1986; 5: 90.

    Google Scholar 

  6. O’Connell MJ: Current status of chemotherapy for advanced pancreatic and gastric cancer. J Clin Oncol 1985; 3: 1032.

    PubMed  Google Scholar 

  7. Douglass HO Jr, Lavin PT, Goudsmit A, et al: An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin-C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277). J Clin Oncol 1984; 2: 1372.

    PubMed  Google Scholar 

  8. Klein HI, Dias Wichramanayake P, Farrokh GR: 5-Fluorouracil, Adriamycin, and methotrexate—a combination protocol for treatment of metastasized stomach cancer. Proc ASCO 1986; 5: 84.

    Google Scholar 

  9. Wils J, Bleiberg H, Dalesio O, et al: An EORTC gastrointestinal group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with Adriamycin in advanced measurable gastric cancer. J Clin Oncol 1986; 4: 1799.

    PubMed  CAS  Google Scholar 

  10. Preusser P, Wilke H, Achterrath W, et al: Advanced gastric carcinoma: A phase II study with etoposide, Adriamycin and split course cisplatin. Proc ASCO 1987; 6: 75.

    Google Scholar 

  11. Bruckner HW, Stablein DM, for the Gastrointestinal Tumor Study Group: Single arm trials of triazinate, cisplatin and methotrexate combinations in advanced gastric cancer, abstract. Proc ASCO 1984; 3: 144.

    Google Scholar 

  12. O’Connell MJ, Schutt M, Moertel CG, et al: Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancer. J Clin Oncol 1987; 5: 83.

    PubMed  Google Scholar 

  13. Bruckner HW, Cohen J: MTX/5-FU trials in gastrointestinal and other cancers. Sem Oncol 1983; 10: 32.

    CAS  Google Scholar 

  14. Houghton JA, Houghton PJ: Basis for the interaction of 5-fluorouracil and leucovorin in colon adenocarcinoma, in Bruckner HW, Rustum YM (eds): Advances in Cancer Chemotherapy: The Current Status of 5-Fluorouracil-Leucovorin Calcium Combination. New York, Park Row, 1984, p 23.

    Google Scholar 

  15. Machover D, Schwarzenberg L, Goldschmidt E, et al: Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study. Cancer Treat Rep 1982; 66: 1803.

    PubMed  CAS  Google Scholar 

  16. Arbuck SG, Douglass HO Jr, Trave F, et al: A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma. J Clin Oncol 1987; 5: 1150.

    PubMed  CAS  Google Scholar 

  17. Trave F, Rustum YM, Goranson J: Synergistic antitumor activity of cisplatin and 5-fluorouracil in mice bearing leukemia L1210 cells, abstract. Proc ASCO 1985; 26: 322.

    Google Scholar 

  18. Burchenal JH, Lokys L, Turkevich J, et al: Rationale of combination chemotherapy, in Prestayko AW, Crooke ST, Carter SK (eds): Cisplatin: Current Status and New Developments. New York, Academic Press, 1980, p 113.

    Google Scholar 

  19. Bruckner HW, Stablein DM, for the Gastrointestinal Tumor Study Group: Sites of treatment failure: Gastrointestinal Tumor Study Group Analyses of gastric, pancreatic and colorectal trials. Cancer Treat Sym 1983; 2: 199.

    Google Scholar 

  20. Lavin PT, Bruckner HW, Plaxe SC, for the Gastrointestinal Tumor Study Group: Studies in prognostic factors relating to chemotherapy for advanced gastric cancer. Cancer 1983; 50: 2016.

    Google Scholar 

  21. Bruckner HW, Lavin P, Plaxe S, et al: Routine clinical chemistries as improved determinates of prognosis for patients with metastatic cancer of the stomach. Oncology 1983; 40: 31.

    Article  PubMed  CAS  Google Scholar 

  22. Bruckner HW, Lavin PT, Plaxe SC, et al: Absolute granulocyte, lymphocyte and monocyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach. JAMA 1982; 247: 1004.

    Article  PubMed  CAS  Google Scholar 

  23. Gastrointestinal Tumor Study Group: A comparison of combination chemotherapy and combined modality for locally advanced gastric carcinoma. Cancer 1982; 49: 1771.

    Article  Google Scholar 

  24. Stablein DM, Carter WH, et al: Analysis of survival data with nonproportional hazard functions. Control Clin Trials 1981; 2: 149.

    Article  PubMed  CAS  Google Scholar 

  25. Kemeny N, Daly J, Reichman B, et al: Intrahepatic or systemic infusion of fluorodeoxyuridine in patient with liver metastases from colorectal carcinoma. Ann Intern Med 1987; 107: 459.

    PubMed  CAS  Google Scholar 

  26. Krook J, Moertel C, Wieand H, et al: Radiation vs sequential chemotherapyradiation-chemotherapy. A study of the North Central Cancer Treatment Group, Duke University, and the Mayo Clinic. Proc ASCO 1986; 5: 82.

    Google Scholar 

  27. Moertel CG, Childs DS, Reitemeirer RI, et al: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969; 2: 865.

    Article  PubMed  CAS  Google Scholar 

  28. Gastrointestinal Tumor Study Group: A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg 1979; 189: 126.

    Google Scholar 

  29. Gastrointestinal Tumor Study Group: Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985; 312: 1465.

    Article  Google Scholar 

  30. Wolmark N, Fisher B, Rockette H, et al: Adjuvant therapy in carcinoma of the colon: five year results of NSABP protocol C-01. Proc ASCO 1987; 6: 92.

    Google Scholar 

  31. Fisher B, Wolmark N, Rockette H, et al: Adjuvant chemotherapy or post-operative radiation for rectal cancer: 5-year results of NSABP R-01. Proc ASCO 1987; 6: 92.

    Google Scholar 

  32. Bruckner HW: Letter to the Editor. Am J Gastroenterol, to be published.

    Google Scholar 

  33. Nakazato H, Imanaga H: Results of surgery for gastric cancer and effect of adjuvant chemotherapy, in Herfarth Ch, Schlag P (eds): Gastric Cancer. Berlin-HeidelbergNew York, Springer, 1979, p 344.

    Google Scholar 

  34. Douglass HO, Stablein D, Bruckner HW, et al: Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. Cancer 1982; 49: 1116.

    Article  Google Scholar 

  35. Kabakow B, Storch JA, Bruckner HW: New multidisciplinary treatment for gastric carcinoma. Digestion 1977; 16: 248.

    Google Scholar 

  36. Douglass HO Jr: Western surgical adjuvant trials in gastric cancers: lessons from current trials to be applied to the future, in: Contemporary Issues in Clinical Oncology. New York, Churchill-Livingston, 1988, p 145.

    Google Scholar 

  37. Douglass HO Jr: Adjuvant chemotherapy-stomach cancer-adjuvant treatment of gastric cancer, in: Cancer Chemotherapy: Challenges for the Future. First Nagoya Intern Symp on Cancer Treatment. Excerpta Medica International Congress Series 729, 1985.

    Google Scholar 

Download references

Authors
  1. H. W. Bruckner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Gastroenterology and Oncology, General Hospital, Celle, Germany

    Jürgen Hotz M.D. (Professor of Medicine, Head) (Professor of Medicine, Head)

  2. Department of Surgery, Division of Abdominal and Transplantation Surgery, Medical University of Hannover, Hannover, Germany

    Hans-Joachim Meyer M.D. (Professor of Surgery) (Professor of Surgery)

  3. Department of Hematology/Oncology, Medical University of Hannover, Hannover, Germany

    H.-J. Schmoll M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag New York, Inc.

About this paper

Cite this paper

Bruckner, H.W. (1989). Gastric Cancer Trials: Implications of the Gastrointestinal Tumor Study Group and the Mount Sinai Medical Center Experience. In: Hotz, J., Meyer, HJ., Schmoll, HJ. (eds) Gastric Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3636-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3636-8_13

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-96955-8

  • Online ISBN: 978-1-4612-3636-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation